|
Index of reports
> Hospitalization (15)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Catapres (Clonidine) hospitalization. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Catapres side effects in female
Reported by a consumer/non-health professional from United States on 2012-07-23
Patient: female
Reactions: Confusional State, Inappropriate Schedule of Drug Administration, Drug Effect Decreased, Hypersensitivity, Drug Hypersensitivity, Injection Site Pain, Encephalopathy, Headache, Erythema, Convulsion, Oedema, Hypertension
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Ampyra
Dosage: 10 mg
Gilenya
Ampyra
Dosage: 20 mg
Start date: 2011-11-01
Catapres
Indication: Hypertension
Start date: 2011-12-01
Copaxone
Start date: 2012-06-05
Zithromax
Start date: 2011-12-01
Other drugs received by patient: Betaseron; Paxil; Trazodone Hydrochloride; Estradiol; Xanax; Lisinopril; Omeprazole
Possible Catapres side effects in male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-14
Patient: male
Reactions: Pancytopenia, Rash, Rheumatoid Arthritis, Malaise, Acute Respiratory Distress Syndrome, Lung Infiltration, Hypertension, Renal Failure Acute, Pneumonitis
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate Sodium
Dosage: unk
Arava
Dosage: unk
Catapres
Dosage: unk
Other drugs received by patient: Protonix; Folic Acid; Prednisone; Multi-Vitamins; Levaquin; Diflucan; Metronidazole
Possible Catapres side effects in male
Reported by a physician from Japan on 2012-05-11
Patient: male, weighing 42.5 kg (93.5 pounds)
Reactions: Nausea, Blood Pressure Decreased, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Catapres
Other drugs received by patient: Zithromax
Possible Catapres side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-05-08
Patient: male
Reactions: Dyskinesia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Catapres
Dosage: 0.075 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
End date: 2011-10-21
Concerta
Dosage: 36 mg
Administration route: Oral
Start date: 2012-04-01
Concerta
Dosage: 36 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-19
End date: 2011-10-20
Risperdal
Dosage: 1 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
End date: 2011-11-20
Possible Catapres side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-22
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Cough, Atrioventricular Block First Degree
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Labetalol
Dosage: 1 df, qid
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2011-06-06
End date: 2011-11-04
Labetalol
Dosage: 1 df, q6h
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Labetalol
Dosage: 900 mg, once/single
Administration route: Oral
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Other drugs received by patient: Synthroid; Aldactone; Amitiza; Clonidine; Aldactone; Prozac; Prilosec; Vitamin D; Valium; Dyazide; Valium
Possible Catapres side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-22
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Cough, Atrioventricular Block First Degree
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Labetalol HCL
Dosage: 1 df, q6h
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Labetalol HCL
Dosage: 1 df, qid
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2011-06-06
End date: 2011-11-04
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Labetalol HCL
Dosage: 900 mg, once/single
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Other drugs received by patient: Prozac; Vitamin D; Synthroid; Aldactone; Valium; Valium; Prilosec; Clonidine; Aldactone; Dyazide; Amitiza
Possible Catapres side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-03-14
Patient: male, weighing 3.1 kg (6.7 pounds)
Reactions: Respiratory Disorder, Hypoglycaemia, Somnolence, Convulsion, Clonic Convulsion, Cyanosis, Feeding Disorder Neonatal, Oxygen Saturation Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Catapres
Indication: Maternal Exposure During Pregnancy
End date: 2012-01-16
Catapres
Indication: Exposure During Breast Feeding
Start date: 2012-01-16
End date: 2012-01-25
Possible Catapres side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-27
Patient: male
Reactions: TIC, Dyskinesia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Concerta
Dosage: 36 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-19
End date: 2011-10-20
Risperdal
Dosage: 1 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
Catapres
Dosage: 0.075 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
End date: 2011-10-21
Possible Catapres side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-02-16
Patient: male
Reactions: Dyskinesia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Catapres
Dosage: 0.075 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
End date: 2011-10-21
Concerta
Dosage: 36 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-10-19
End date: 2011-10-20
Risperdal
Dosage: 1 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
Possible Catapres side effects in male
Reported by a health professional (non-physician/pharmacist) from France on 2012-01-30
Patient: male
Reactions: Dyskinesia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Risperdal
Dosage: 1 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
Catapres
Dosage: 0.075 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2009-01-01
Concerta
Dosage: 36 mg
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Start date: 2011-11-19
End date: 2011-11-20
Possible Catapres side effects in female
Reported by a consumer/non-health professional from United States on 2012-01-09
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Drug Ineffective, Labile Hypertension, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Atrioventricular Block First Degree, Cough
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Labetalol HCL
Dosage: 1 df, qid
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Labetalol HCL
Dosage: 1 df, q6h
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2001-06-06
End date: 2011-11-04
Labetalol HCL
Dosage: 900 mg, once/single
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Gilenya
Indication: Demyelination
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Other drugs received by patient: Synthroid; Valium; Prilosec; Prozac; Aldactone; Amitiza; Valium; Aldactone; Dyazide; Clonidine; Vitamin D
Possible Catapres side effects in female
Reported by a physician from United States on 2012-01-09
Patient: female, weighing 65.4 kg (143.9 pounds)
Reactions: Blood Pressure Increased, Dyspnoea, Labile Hypertension, Drug Ineffective, Urinary Incontinence, Blood Potassium Increased, Headache, Hypertensive Crisis, Overdose, Bronchitis, Atrioventricular Block First Degree, Cough
Adverse event resulted in: life threatening event, hospitalization, disablity
Drug(s) suspected as cause:
Lopressor
Dosage: 50 mg, tid
Administration route: Oral
Gilenya
Dosage: 0.5 mg, qd
Administration route: Oral
Indication: Multiple Sclerosis
Start date: 2001-06-06
End date: 2011-11-04
Levothroid
Dosage: 300 ug, unk
Administration route: Oral
Labetalol HCL
Dosage: 900 mg, once/single
Administration route: Oral
Labetalol HCL
Dosage: 1 df, qid
Gilenya
Indication: Demyelination
Labetalol HCL
Dosage: 1 df, q6h
Administration route: Oral
Cardizem LA
Dosage: unk ukn, unk
Indication: Coronary Artery Disease
Levothroid
Dosage: 600 ug, unk
Administration route: Oral
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Zestril
Dosage: 10 mg, bid
Catapres
Dosage: 0.1 mg, tid (prn)
Administration route: Oral
Other drugs received by patient: Amitiza; Prozac; Dyazide; Clonidine; Vitamin D; Aldactone; Aldactone; Valium; Synthroid; Valium; Prilosec
Possible Catapres side effects in 63 year old male
Reported by a physician from France on 2011-12-29
Patient: 63 year old male
Reactions: Confusional State, Agitation, Dysphoria, Aphasia, Disorientation, Speech Disorder, Hallucination, Escherichia Sepsis, Urinary Tract Infection, Inadequate Analgesia, Abnormal Behaviour, Indifference, Aggression, Dysphonia, Visual Impairment, Gastrointestinal Disorder, Suicide Attempt
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Morphine
Dosage: 0.05 mg, once/hour, intrathecal, mg, once/hour, intrathecal
Start date: 2009-05-14
Morphine
Dosage: 0.05 mg, once/hour, intrathecal, mg, once/hour, intrathecal
Start date: 2005-01-01
End date: 2009-04-01
Prialt
Dosage: see image
Indication: Neuralgia
Start date: 2009-05-12
End date: 2009-05-19
Prialt
Dosage: see image
Indication: Neuralgia
Start date: 2009-04-25
End date: 2009-04-27
Prialt
Dosage: see image
Indication: Neuralgia
Start date: 2009-05-19
End date: 2009-05-25
Prialt
Dosage: see image
Indication: Neuralgia
Start date: 2009-04-12
End date: 2009-04-25
Prialt
Dosage: see image
Indication: Neuralgia
Start date: 2009-04-27
End date: 2009-05-12
Catapres
Start date: 2005-01-01
Other drugs received by patient: Atenolol; Nitriderm (Glyceryl Trinitrate); Zopiclone (Zopiclone); Aspirin; Transipeg (Macrogol); Omeprazole; Amiloride HCL W / Hydrochlorothiazide (Amiloride Hydrochloride Hydrochlo
Possible Catapres side effects in 10 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-30
Patient: 10 year old male
Reactions: Overdose, Miosis, Hypotension, Hyporesponsive To Stimuli, Somnolence
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Kapvay
Dosage: 0.2 mg
Start date: 2011-09-01
Catapres
Possible Catapres side effects in
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-06
Patient:
Reactions: Respiratory Failure
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Catapres
Indication: Maternal Exposure During Pregnancy
Chirocaine
Indication: Maternal Exposure During Pregnancy
Sufentanil Citrate
Indication: Maternal Exposure During Pregnancy
|
